Center of Biotherapy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Front Immunol. 2021 Apr 9;12:662305. doi: 10.3389/fimmu.2021.662305. eCollection 2021.
Systemic lupus erythematosus (SLE) is a chronic multi-organ autoimmune disease involving the production of a wide range of autoantibodies and complement activation. The production of these high-affinity autoantibodies requires T cell/B cell collaboration as well as germinal center (GC) formation. T follicular regulatory cells (TFRs) are functional specialized T regulatory cells (Tregs) that safeguard against both self-reactive T and B cells. However, recent evidence suggests that TFRs are not always stable and can lose Foxp3 expression to become pathogenic "ex-TFRs" that gain potent effector functions. In this review, we summarize the literature on intrinsic and extrinsic mechanisms of regulation of TFR stability and discuss the potential role of TFR reprogramming in autoantibody production and SLE pathogenesis.
系统性红斑狼疮(SLE)是一种慢性多器官自身免疫性疾病,涉及多种自身抗体的产生和补体的激活。这些高亲和力自身抗体的产生需要 T 细胞/B 细胞的协作以及生发中心(GC)的形成。滤泡辅助性 T 细胞(TFRs)是功能性的特异性 T 调节细胞(Tregs),可防止自身反应性 T 细胞和 B 细胞的产生。然而,最近的证据表明,TFRs 并不总是稳定的,它们可以失去 Foxp3 表达而成为获得强大效应功能的致病性“前 TFRs”。在这篇综述中,我们总结了关于 TFR 稳定性的内在和外在调节机制的文献,并讨论了 TFR 重编程在自身抗体产生和 SLE 发病机制中的潜在作用。